Alice Cleynen
- Hematology top 5%
- Multiple Myeloma Research and Treatments 8
-
- RNA and protein synthesis mechanisms 3
- Gene expression and cancer classification 3
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Degradation and Inhibitors 2
-
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 2
-
- Bayesian Methods and Mixture Models 3
- Co-authors
- Hervé Avet‐LoiseauMichel AttalJill CorreNikhil C. MunshiMarie‐Lorraine ChrétienLaure BuissonNiccolò BolliP. Leif Bergsagel
- Cited by
- HematologyOncologyImmunology
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Alice Cleynen
16 papers receiving 502 citations
Peers
Comparison fields: 5 of 80
- Hematology 270
- Oncology 174
- Immunology 121
- Molecular Biology 314
- Cancer Research 67
Countries citing papers authored by Alice Cleynen
This map shows the geographic impact of Alice Cleynen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Cleynen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Cleynen more than expected).
Fields of papers citing papers by Alice Cleynen
This network shows the impact of papers produced by Alice Cleynen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Cleynen. The network helps show where Alice Cleynen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alice Cleynen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2018 | 167 | |
| 4 | 2018 | 36 | |
| 5 | 2018 | 86 | |
| 6 | 2017 | 25 | |
| 7 | 2017 | 43 | |
| 8 | 2017 | 81 | |
| 9 | 2015 | 28 | |
| 10 | 2015 | 2 | |
| 11 | 2015 | 2 | |
| 12 | 2014 | 19 | |
| 13 | 2014 | 1 | |
| 14 | 2014 | 0 | |
| 15 | 2014 | 9 | |
| 16 | 2013 | 1 | |
| 17 | A Generic Implementation of the Pruned Dynamic Programing Algorithm | 2012 | 4 |
About Alice Cleynen
Alice Cleynen is a scholar working on Hematology, Cancer Research and Statistics and Probability, having authored 17 papers that have together received 506 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Bayesian Methods and Mixture Models (3 papers), RNA and protein synthesis mechanisms (3 papers), Gene expression and cancer classification (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (270 citations), Oncology (174 citations) and Immunology (121 citations). Alice Cleynen has collaborated with scholars based in France, United States and Australia. Frequent co-authors include Hervé Avet‐Loiseau, Michel Attal, Jill Corre, Nikhil C. Munshi, Marie‐Lorraine Chrétien, Laure Buisson, Niccolò Bolli, P. Leif Bergsagel, Sahar Kassem and Mark J. Smyth. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.